Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA JUBILANT PHARMOVA CIPLA/
JUBILANT PHARMOVA
 
P/E (TTM) x 32.2 -2,647.7 - View Chart
P/BV x 5.2 1.7 307.9% View Chart
Dividend Yield % 0.6 0.9 64.7%  

Financials

 CIPLA   JUBILANT PHARMOVA
EQUITY SHARE DATA
    CIPLA
Mar-23
JUBILANT PHARMOVA
Mar-23
CIPLA/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs1,185496 239.2%   
Low Rs852269 317.0%   
Sales per share (Unadj.) Rs281.9394.4 71.5%  
Earnings per share (Unadj.) Rs35.1-4.1 -862.4%  
Cash flow per share (Unadj.) Rs49.730.7 161.7%  
Dividends per share (Unadj.) Rs8.505.00 170.0%  
Avg Dividend yield %0.81.3 63.8%  
Book value per share (Unadj.) Rs289.2338.6 85.4%  
Shares outstanding (eoy) m807.15159.28 506.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.61.0 372.9%   
Avg P/E ratio x29.0-93.8 -30.9%  
P/CF ratio (eoy) x20.512.4 164.8%  
Price / Book Value ratio x3.51.1 312.0%  
Dividend payout %24.2-122.7 -19.7%   
Avg Mkt Cap Rs m822,16460,873 1,350.6%   
No. of employees `000NANA-   
Total wages/salary Rs m38,30121,660 176.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,53162,817 362.2%  
Other income Rs m5,121383 1,336.2%   
Total revenues Rs m232,65363,201 368.1%   
Gross profit Rs m48,0797,317 657.1%  
Depreciation Rs m11,7215,540 211.6%   
Interest Rs m1,0951,882 58.2%   
Profit before tax Rs m40,384278 14,536.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,029927 1,298.1%   
Profit after tax Rs m28,355-649 -4,370.3%  
Gross profit margin %21.111.6 181.4%  
Effective tax rate %29.8333.5 8.9%   
Net profit margin %12.5-1.0 -1,206.6%  
BALANCE SHEET DATA
Current assets Rs m168,05137,624 446.7%   
Current liabilities Rs m50,33317,724 284.0%   
Net working cap to sales %51.731.7 163.3%  
Current ratio x3.32.1 157.3%  
Inventory Days Days7325 298.8%  
Debtors Days Days756 11.7%  
Net fixed assets Rs m117,31871,668 163.7%   
Share capital Rs m1,614159 1,014.7%   
"Free" reserves Rs m231,84553,772 431.2%   
Net worth Rs m233,46053,931 432.9%   
Long term debt Rs m031,104 0.0%   
Total assets Rs m290,067109,292 265.4%  
Interest coverage x37.91.1 3,299.6%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.6 136.5%   
Return on assets %10.21.1 899.8%  
Return on equity %12.1-1.2 -1,009.6%  
Return on capital %17.82.5 699.5%  
Exports to sales %22.60-   
Imports to sales %8.94.1 217.5%   
Exports (fob) Rs m51,516NA-   
Imports (cif) Rs m20,2022,564 787.9%   
Fx inflow Rs m64,2827,100 905.4%   
Fx outflow Rs m20,2022,564 787.9%   
Net fx Rs m44,0804,536 971.9%   
CASH FLOW
From Operations Rs m32,3776,607 490.1%  
From Investments Rs m-23,885-5,444 438.7%  
From Financial Activity Rs m-9,583-1,567 611.6%  
Net Cashflow Rs m-968301 -321.5%  

Share Holding

Indian Promoters % 13.4 47.4 28.3%  
Foreign collaborators % 20.0 3.3 609.1%  
Indian inst/Mut Fund % 50.0 23.2 215.7%  
FIIs % 25.7 20.3 126.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 49.3 134.9%  
Shareholders   425,731 86,588 491.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs Jubilant Pharmova

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Jubilant Pharmova Share Price Performance

Period Cipla Jubilant Pharmova S&P BSE HEALTHCARE
1-Day 1.94% -0.54% 1.18%
1-Month 1.25% 2.20% -0.75%
1-Year 68.02% 109.28% 61.82%
3-Year CAGR 22.53% -6.79% 18.16%
5-Year CAGR 23.24% -2.78% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Jubilant Pharmova share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Jubilant Pharmova the stake stands at 50.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Jubilant Pharmova.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Jubilant Pharmova paid Rs 5.0, and its dividend payout ratio stood at -122.7%.

You may visit here to review the dividend history of Cipla, and the dividend history of Jubilant Pharmova.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.